SE417196B - Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer - Google Patents
Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminerInfo
- Publication number
- SE417196B SE417196B SE7701795A SE7701795A SE417196B SE 417196 B SE417196 B SE 417196B SE 7701795 A SE7701795 A SE 7701795A SE 7701795 A SE7701795 A SE 7701795A SE 417196 B SE417196 B SE 417196B
- Authority
- SE
- Sweden
- Prior art keywords
- metylamines
- propandiols
- dioxan
- intermediates
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31322172A | 1972-12-08 | 1972-12-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7701795L SE7701795L (sv) | 1977-02-17 |
SE417196B true SE417196B (sv) | 1981-03-02 |
Family
ID=23214841
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7316586A SE403377B (sv) | 1972-12-08 | 1973-12-07 | Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan |
SE7701796A SE428378B (sv) | 1972-12-08 | 1977-02-17 | Analogiforfarande for framstellning av droxanderivat |
SE7701795A SE417196B (sv) | 1972-12-08 | 1977-02-17 | Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7316586A SE403377B (sv) | 1972-12-08 | 1973-12-07 | Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan |
SE7701796A SE428378B (sv) | 1972-12-08 | 1977-02-17 | Analogiforfarande for framstellning av droxanderivat |
Country Status (27)
Country | Link |
---|---|
JP (2) | JPS5734835B2 (xx) |
AR (3) | AR206306A1 (xx) |
AT (2) | AT330773B (xx) |
BE (1) | BE808340A (xx) |
BG (4) | BG21223A3 (xx) |
CA (2) | CA1014560A (xx) |
CH (4) | CH614439A5 (xx) |
CS (3) | CS193480B2 (xx) |
CY (1) | CY1017A (xx) |
DD (3) | DD109625A5 (xx) |
DE (1) | DE2361340C2 (xx) |
DK (1) | DK134717B (xx) |
ES (4) | ES421291A1 (xx) |
FR (1) | FR2209578B1 (xx) |
GB (2) | GB1455997A (xx) |
HK (1) | HK60479A (xx) |
HU (2) | HU168620B (xx) |
IE (1) | IE40226B1 (xx) |
IL (1) | IL43773A (xx) |
KE (1) | KE2976A (xx) |
MY (1) | MY8000064A (xx) |
NL (1) | NL7316839A (xx) |
PH (2) | PH15197A (xx) |
SE (3) | SE403377B (xx) |
SU (4) | SU578001A3 (xx) |
YU (3) | YU36171B (xx) |
ZA (1) | ZA739207B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013169531A1 (en) * | 2012-05-09 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Methods for making oxetan-3-ylmethanamines |
LV14983B (lv) * | 2013-10-15 | 2015-06-20 | Olainfarm, A/S | Fenibuta ražošanas starpproduktu iegūšanas paņēmiens |
-
1973
- 1973-01-01 AR AR251422A patent/AR206306A1/es active
- 1973-12-04 ZA ZA00739207A patent/ZA739207B/xx unknown
- 1973-12-04 IE IE2190/73A patent/IE40226B1/xx unknown
- 1973-12-06 PH PH15299A patent/PH15197A/en unknown
- 1973-12-06 CA CA187,516A patent/CA1014560A/en not_active Expired
- 1973-12-07 HU HUEI510A patent/HU168620B/hu unknown
- 1973-12-07 NL NL7316839A patent/NL7316839A/xx not_active Application Discontinuation
- 1973-12-07 AT AT1026073A patent/AT330773B/de not_active IP Right Cessation
- 1973-12-07 CA CA187,636A patent/CA1024150A/en not_active Expired
- 1973-12-07 FR FR7343848A patent/FR2209578B1/fr not_active Expired
- 1973-12-07 CH CH17977A patent/CH614439A5/xx not_active IP Right Cessation
- 1973-12-07 BE BE1005568A patent/BE808340A/xx not_active IP Right Cessation
- 1973-12-07 ES ES73421291A patent/ES421291A1/es not_active Expired
- 1973-12-07 SE SE7316586A patent/SE403377B/xx unknown
- 1973-12-07 AT AT1026173A patent/AT332396B/de not_active IP Right Cessation
- 1973-12-07 IL IL43773A patent/IL43773A/xx unknown
- 1973-12-07 DK DK663373AA patent/DK134717B/da not_active IP Right Cessation
- 1973-12-07 HU HUEI511A patent/HU168763B/hu unknown
- 1973-12-07 AR AR251423A patent/AR212416A1/es active
- 1973-12-07 CH CH1720873A patent/CH619219A5/de not_active IP Right Cessation
- 1973-12-07 SU SU7301978316A patent/SU578001A3/ru active
- 1973-12-07 ES ES73421290A patent/ES421290A1/es not_active Expired
- 1973-12-07 YU YU3185/73A patent/YU36171B/xx unknown
- 1973-12-07 CH CH1720973A patent/CH605903A5/xx not_active IP Right Cessation
- 1973-12-07 SU SU731977567A patent/SU587861A3/ru active
- 1973-12-07 YU YU3184/73A patent/YU35447B/xx unknown
- 1973-12-08 JP JP14024573A patent/JPS5734835B2/ja not_active Expired
- 1973-12-08 BG BG025193A patent/BG21223A3/xx unknown
- 1973-12-08 DE DE2361340A patent/DE2361340C2/de not_active Expired
- 1973-12-08 JP JP48140246A patent/JPS5742633B2/ja not_active Expired
- 1973-12-08 BG BG027548A patent/BG22386A3/xx unknown
- 1973-12-08 BG BG028633A patent/BG21409A3/xx unknown
- 1973-12-08 BG BG028632A patent/BG26205A4/xx unknown
- 1973-12-10 CS CS738528A patent/CS193480B2/cs unknown
- 1973-12-10 DD DD175231A patent/DD109625A5/xx unknown
- 1973-12-10 GB GB5711373A patent/GB1455997A/en not_active Expired
- 1973-12-10 CS CS765892A patent/CS222209B2/cs unknown
- 1973-12-10 DD DD175232A patent/DD110864A5/xx unknown
- 1973-12-10 CS CS738529A patent/CS222208B2/cs unknown
- 1973-12-10 GB GB2900376A patent/GB1455998A/en not_active Expired
- 1973-12-10 DD DD179119*A patent/DD115653A5/xx unknown
- 1973-12-10 CY CY1017A patent/CY1017A/xx unknown
-
1975
- 1975-01-27 SU SU752100370A patent/SU648081A3/ru active
- 1975-02-19 SU SU752106121A patent/SU663305A3/ru active
- 1975-05-14 AR AR258799A patent/AR212012A1/es active
-
1976
- 1976-01-28 ES ES444716A patent/ES444716A1/es not_active Expired
- 1976-02-04 ES ES444911A patent/ES444911A1/es not_active Expired
- 1976-04-30 PH PH18384A patent/PH14923A/en unknown
-
1977
- 1977-02-17 SE SE7701796A patent/SE428378B/xx unknown
- 1977-02-17 SE SE7701795A patent/SE417196B/xx unknown
-
1979
- 1979-07-03 KE KE2976A patent/KE2976A/xx unknown
- 1979-08-23 HK HK604/79A patent/HK60479A/xx unknown
- 1979-09-06 CH CH805879A patent/CH630914A5/de not_active IP Right Cessation
-
1980
- 1980-04-22 YU YU1093/80A patent/YU36020B/xx unknown
- 1980-12-30 MY MY64/80A patent/MY8000064A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE400280B (sv) | 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner | |
SE407579B (sv) | Forfarande for framstellning av n-fosfonometylglycin | |
SE7710602L (sv) | Mellanprodukter for framstellning av bensoxazolderivat | |
NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
SE397257B (sv) | Forfarande for framstellning av sackaroshaltiga sotningsmedel | |
IT975971B (it) | Procedimento per la preparazione di clorosilani | |
NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
SE386892B (sv) | Forfarande for framstellning av oxaminoforeningar | |
SE382053B (sv) | Forfarande for framstellning av bifenylylalkanoylaminopyridiner | |
SE389856B (sv) | Forfarande for framstellning av alkaliperkarbonater | |
SE383151B (sv) | Forfarande for framstellning av 1-hydroxi-2-pyridoner | |
SE393111B (sv) | Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin | |
SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
SE393808B (sv) | Forfarande for framstellning av isomaltit | |
SE415355B (sv) | Forfarande for framstellning av fosfonotioureider | |
NO142624C (no) | Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater | |
AR197040A1 (es) | Procedimiento de preparacion de nuevas bifenilacetamidas | |
IT956743B (it) | Procedimento per la preparazione di composti alchilsolfonati | |
SE391717B (sv) | Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner | |
SE417196B (sv) | Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer | |
IT996099B (it) | Procedimento di preparazione di amminoantrachinone | |
DK555680A (da) | Benzocycloptathiophenderivater til anvendelse som mellemprodukter ved fremstilling af terapeutisk virksomme benzocycloptathiophenderivater | |
SE389862B (sv) | Forfarande for framstellning av alfa-6-deoxitetracykliner | |
IT977792B (it) | Procedimento per la preparazione di cianidrine |